Page last updated: 2024-10-21

pk 11195 and Multiple System Atrophy Syndrome

pk 11195 has been researched along with Multiple System Atrophy Syndrome in 2 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dodel, R1
Spottke, A1
Gerhard, A2
Reuss, A1
Reinecker, S1
Schimke, N1
Trenkwalder, C1
Sixel-Döring, F1
Herting, B1
Kamm, C1
Gasser, T1
Sawires, M1
Geser, F1
Köllensperger, M1
Seppi, K1
Kloss, M1
Krause, M1
Daniels, C1
Deuschl, G1
Böttger, S1
Naumann, M1
Lipp, A1
Gruber, D1
Kupsch, A1
Du, Y1
Turkheimer, F2
Brooks, DJ2
Klockgether, T1
Poewe, W1
Wenning, G1
Schade-Brittinger, C1
Oertel, WH1
Eggert, K1
Banati, RB1
Goerres, GB1
Cagnin, A1
Myers, R1
Gunn, RN1
Good, CD1
Mathias, CJ1
Quinn, N1
Schwarz, J1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Double-blind, Randomised, Placebo-controlled Parallel Group Study to Investigate the Effect of EGCG Supplementation on Disease Progression of Patients With Multiple System Atrophy (MSA)[NCT02008721]Phase 392 participants (Actual)Interventional2014-01-31Completed
An Open Label, Single Site, 48 Week, Randomised Controlled Trial Evaluating the Safety and Efficacy of Exenatide Once-weekly in the Treatment of Patients With Multiple System Atrophy[NCT04431713]Phase 250 participants (Anticipated)Interventional2020-09-16Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for pk 11195 and Multiple System Atrophy Syndrome

ArticleYear
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).
    Movement disorders : official journal of the Movement Disorder Society, 2010, Jan-15, Volume: 25, Issue:1

    Topics: Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Humans; Isoquinolines; Magnetic Resonan

2010
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).
    Movement disorders : official journal of the Movement Disorder Society, 2010, Jan-15, Volume: 25, Issue:1

    Topics: Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Humans; Isoquinolines; Magnetic Resonan

2010
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).
    Movement disorders : official journal of the Movement Disorder Society, 2010, Jan-15, Volume: 25, Issue:1

    Topics: Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Humans; Isoquinolines; Magnetic Resonan

2010
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).
    Movement disorders : official journal of the Movement Disorder Society, 2010, Jan-15, Volume: 25, Issue:1

    Topics: Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Humans; Isoquinolines; Magnetic Resonan

2010

Other Studies

1 other study available for pk 11195 and Multiple System Atrophy Syndrome

ArticleYear
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.
    Neurology, 2003, Sep-09, Volume: 61, Issue:5

    Topics: Aged; Carbon Radioisotopes; Humans; Isoquinolines; Male; Microglia; Middle Aged; Multiple System Atr

2003